Kenvue Inc. (KVUE) Valuation
Historical valuation analysis based on 867 data points (2023-05-04 to 2026-10-16)
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and...
Kenvue Inc. (KVUE) currently trades at a P/E ratio of 21.91 (historical range: 18.95–44.55, median: 23.62), placing it at the 24th percentile — below its historical average, P/S ratio of 2.36 (range: 1.81–3.10, 37th percentile — below its historical average), EV/EBITDA of 16.66 (range: 11.83–26.19, 35th percentile).
Kenvue Inc. trades below its historical valuation range, with most metrics below their median levels.
Historical Valuation Metrics
| Metric | Current | Median | %ile | Assessment |
|---|---|---|---|---|
| P/E Ratio | 21.91 | 23.62 | 24th | below its historical average |
| P/S Ratio | 2.36 | 2.44 | 37th | below its historical average |
| EV/EBITDA | 16.66 | 17.46 | 35th | below its historical average |
| FCF Yield | 5.27% | 5.20% | 54th | near its historical average |
Kenvue Inc. (KVUE) Valuation & P/E History
Kenvue Inc. (KVUE) is a US-listed stock operating in the Consumer Defensive sector, specifically the Perfumes, Cosmetics & Other Toilet Preparations industry currently trading at $18.85 with a market capitalization of $36.2 billion. This page provides historical valuation analysis for KVUE based on 867 data points covering 2023-05-04 to 2026-10-16. The P/E ratio of 21.91 is below the historical median of 23.62, placing KVUE at the 24th percentile of its valuation range. The P/S ratio of 2.36 compares to a median of 2.44.
KVUE Valuation Metrics & Historical Range
The valuation table above shows Kenvue Inc.'s current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether KVUE is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests KVUE is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for Kenvue Inc..
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is KVUE Overvalued or Undervalued?
Kenvue Inc. trades below its historical valuation range, with most metrics below their median levels. The overall valuation percentile of 32 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive KVUE is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full KVUE analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.KVUE trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.